Achromobacter xylosoxidans: Characterization of Strains in Brazilian Cystic Fibrosis Patients-Reference-Cited by-同舟云学术

Achromobacter xylosoxidans: Characterization of Strains in Brazilian Cystic Fibrosis Patients

Published:2011-10 Issue:10 Volume:49 Page:3649-3651
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Pereira Rosana H. V.¹,Carvalho-Assef Ana Paula²,Albano Rodolpho M.³,Folescu Tania W.⁴,Jones Marcia C. M. F.¹,Leão Robson S.¹,Marques Elizabeth A.¹⁵

Affiliation:

1. Departamento de Microbiologia, Imunologia e Parasitologia, Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

2. Laboratório de Pesquisa em Infecção Hospitalar, Instituto Oswaldo Cruz, Rio de Janeiro, Brazil

3. Departamento de Bioquímica, Instituto de Biologia Roberto Alcântara Gomes, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

4. Instituto Fernandes Figueira, Fundação Instituto Oswaldo Cruz, Rio de Janeiro, Brazil

5. Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

Abstract

ABSTRACT We investigated the possibility of cross-infection among cystic fibrosis patients in two Brazilian reference centers. Achromobacter xylosoxidans isolates ( n = 122) were recovered over a 5-year period from 39 patients. Isolates were genetically heterogeneous, but one genotype was present in 56% of the patients, suggesting that cross-infection may have occurred.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.05283-11

Reference19 articles.

1. Cystic Fibrosis Patient with Burkholderia pseudomallei Infection Acquired in Brazil

2. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance;De Baets F.;J. Cyst. Fibros.,2007

3. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008;Emerson J.;Pediatr. Pulmonol.,2010

4. GilliganP. H. KiskaD. L. ApplemanM. D.. 2006. Cumitech 43, Cystic fibrosis microbiology. Coordinating ed., ApplemanM. D.. ASM Press, Washington, DC.

5. Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative in vitro activities of eravacycline in combination with colistin, meropenem, or ceftazidime against various Achromobacter spp. strains isolated from patients with cystic fibrosis;Journal of Chemotherapy;2023-05-21

2. Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosis;Journal of Cystic Fibrosis;2023-03

3. Achromobacter spp. prevalence and adaptation in cystic fibrosis lung infection;Microbiological Research;2022-10

4. Opportunistic Pathogens in Cystic Fibrosis: Epidemiology and Pathogenesis of Lung Infection;Journal of the Pediatric Infectious Diseases Society;2022-09-01

5. Characterization of the Achromobacter xylosoxidans Type VI Secretion System and Its Implication in Cystic Fibrosis;Frontiers in Cellular and Infection Microbiology;2022-06-16